Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kirsten Reichwald
Pharmacokinetics, Immunogenicity, Safety and Preliminary Efficacy of Subcutaneous Turoctocog Alfa Pegol in Previously Treated Patients With Severe Hemophilia a (Alleviate 1)
Journal of Thrombosis and Haemostasis
Medicine
Hematology
TL1A Induces TCR Independent IL-6 and TNF-α Production and Growth of PLZF+ Leukocytes
PLoS ONE
Multidisciplinary
Related publications
The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A
Drugs in R and D
Pharmacology
Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
OA05.01 Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated With Anti-Pd-(L)1 Therapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Turoctocog Alfa Pegol Provides Effective Management for Major and Minor Surgical Procedures in Patients Across All Age Groups With Severe Haemophilia A: Full Data Set From the Pathfinder 3 and 5 Phase III Trials
Haemophilia
Medicine
Genetics
Hematology
Population Pharmacokinetics of Subcutaneous and Intradermal Glucagon in Patients With Type 1 Diabetes
Clinical Therapeutics
Pharmacology
296 Pharmacokinetics, Clinical Efficacy and Safety of Lidocaine in Asphyxiated Newborns Treated With Therapeutic Hypothermia
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Improved Treatment Satisfaction With a New Human Subcutaneous Immunoglobulin (SCIG 20%) in Patients Previously Treated With IVIG
Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Multi-Center Post-Marketing Surveillance Study of Recombinant Factor VIII (Recombinate) in Previously Treated Patients With Hemophilia A
Japanese Journal of Thrombosis and Hemostasis
Safety and Efficacy of the Addition of Simvastatin to Cetuximab in Previously Treated KRAS Mutant Metastatic Colorectal Cancer Patients
Investigational New Drugs
Oncology
Pharmacology
